Provided by Tiger Trade Technology Pte. Ltd.

Progress

43.42
-0.9400-2.12%
Post-market: 43.420.00000.00%19:30 EDT
Volume:331.73K
Turnover:14.53M
Market Cap:1.78B
PE:20.97
High:44.99
Open:44.17
Low:43.38
Close:44.36
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:0.89
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.52
PE(LYR):26.16

Loading ...

A.D.Works Group Outlines Q2 FY2026 Progress and Growth Strategy

TIPRANKS
·
Aug 06

SALA Corporation Reports 71% Progress on Share Buyback Program

TIPRANKS
·
Aug 06

Casino, Guichard-Perrachon Earnings Call Shows Fragile Progress

TIPRANKS
·
Aug 06

Webjet Updates ASX on Progress of On‑Market Share Buy‑Back

TIPRANKS
·
Aug 06

DigitalX Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Aug 06

SolarEdge's Stock is Shedding a Quarter of Its Value as Sales Woes Trump AI Progress

Dow Jones
·
Aug 06

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Aug 05

Does Elliott’s Strategic Review Push and KCGM Expansion Progress Change The Bull Case For Northern Star Resources (ASX:NST)?

Simply Wall St.
·
Aug 05

Hachijuni Nagano Bank Reports Progress on 2026 Share Buyback Program

TIPRANKS
·
Aug 05

Sompo Holdings Reports Progress on 2026 Share Buyback Program

TIPRANKS
·
Aug 05

SHIB Veteran Shares Ecosystem Progress With Key Warning on 'Official' Accounts

utoday
·
Aug 05

CTS Co., Ltd. Reports Progress on Treasury Share Repurchase Program

TIPRANKS
·
Aug 05

DigitalX Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Aug 05

Dyno Nobel Updates Market on Progress of On‑Market Share Buy‑Back

TIPRANKS
·
Aug 05

Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress

TIPRANKS
·
Aug 05

Dow, S&P 500 Hit Records as US-Iran Talks Progress; SanDisk Jumps 10%

TradingKey
·
Aug 05

Hold Rating Maintained as Pipeline Progress Offsets Long-Term Uncertainty; Price Target Reaffirmed at $16

TIPRANKS
·
Aug 05

Analyst Affirms Buy on Stoke Therapeutics as Phase 3 EMPEROR Trial Progress and Strong Cash Position Support Clear Path to 2028 Launch

TIPRANKS
·
Aug 05

AstraZeneca Advances Early Combo Study With AZD0780 and AZD4954, Signaling Steady Pipeline Progress

TIPRANKS
·
Aug 05

Ams-Osram Results Show Progress on New Opportunities

Dow Jones
·
Aug 04